Targeted GBA -specific sequencing in patients reporting LBSD in the future will help to clarify the prevalence of this highly significant class of pathogenic mutations.
← all excerpts
Phenotypic Heterogeneity among <i>GBA</i> p.R202X Carriers in Lewy Body Spectrum Disorders.
1
—
—